GLADEL is an international group formed by experts in the field of SLE, including more than 50 rheumatology research centres located in main cities from more than 12 Latin American countries. The group's philosophy is inclusive, enthusiastic and looking forward to the incorporation of new centers and countries within Latin America, as new projects arise linked to the above-mentioned objectives. Decisions are always taken by consensus among equals.
2023 Mar.
Predictors of severe hemolytic anemia and its impact on major outcomes in systemic lupus erythematosus: Data from a multiethnic Latin American cohort
2021 Sep.
Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review
2021 Jun.
Factors associated with neuropsychiatric involvement in Latin American patients with systemic lupus erythematosus.
2021 Jan.
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.